Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| RXII (RXi Pharmaceuticals Corporation) | NA | -42.11% | -79.79% | -74.47% | -22.99% | NA | NA | … | … |
Data as of 11/16/2018, Common starting date is 03/13/2008
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| RXII (RXi Pharmaceuticals Corporation) | 03/13/2008 | 11/16/2018 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -23.26 | -42.11 | -79.79 | -74.47 | -22.99 | NA | NA | … | … | -40.65 | -22.24 | -98.13 | -76.13 | -44.83 | 12,788.89 | -99.45 |
| Sharpe Ratio | NA | -0.24 | -0.48 | -0.54 | -0.16 | NA | NA | … | … | -0.23 | -0.60 | -0.50 | -1.09 | -0.74 | 14.80 | -0.12 |
| Standard Deviation(%) | NA | 260.53 | 217.98 | 177.32 | 431.65 | NA | NA | … | … | 276.22 | 69.51 | 264.61 | 86.71 | 85.94 | 862.87 | 703.30 |
| Draw Down(%) | NA | 93.88 | 99.22 | 99.95 | 100.00 | NA | NA | … | … | 93.88 | 49.71 | 98.14 | 77.64 | 74.72 | 98.52 | 99.88 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 11/16/2018, Common starting date is 03/13/2008
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RXII (RXi Pharmaceuticals Corporation) |
-95.03%
May 2013 – May 2016 |
-83.81%
Jun 2013 – Jun 2018 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| RXII (RXi Pharmaceuticals Corporation) |
157.02%
Dec 2012 – Dec 2015 |
12.20%
Jan 2013 – Jan 2018 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart